Goserelin – Management of endometriosis; pre-operative management of uterine fibroids – as per NICE NG 73

Drug Name (Brand)	Goserelin *(Zoladex®)*
Indication	Management of endometriosis; pre-operative management of uterine fibroids – as per NICE NG 73
Traffic Light Classification	Amber shared care agreement
NICE TA (plus link)	Norfolk and Waveney Formulary Overview \| Endometriosis: diagnosis and management \| Guidance \| NICE
Further Information: NICE recommendations, summary of meeting discussions, links to additional supporting docs etc. November 2007: Revision of a shared care agreement orginally developed in 2005. The shared care agreement, “LHRH Agonist Treatment”, also covers use of leuprorelin acetate and triptorelin. GPs may switch their patients to the most appropriate product irrespective of the treatment initated by the hospital. May 2012: Revised version supported by the TAG and use approved by the NHS N&W D&TCG. September 2014: The TAG supported continued use of the revised Shared Care Agreement for this treatment. September 2014: The Norfolk & Waveney CCGs D&TCG noted and supported the TAG recommendation. September 2017: The TAG supported continued use of the revised Shared Care Agreement for this treatment. September 2017: The Norfolk & Waveney CCGs D&TCG noted and supported the TAG recommendation. November 2017: The TAG acknowledged NICE NG 73 (September 2017) – Endometriosis: diagnosis and management, which updates and replaces the recommendations on endometriosis in NICE’s fertility problems guideline (CG 156), which includes recommendations on fertility tests and treatments such as assisted reproduction.
Date of TAG recommendation / ratification		9/1/2014	Review Date